Abstract
AbstractAntibiotic resistance is a hot public health issue. Former MRSA gives the way to ESBL, and recently brand new CRE and VRE. New antibiotics are discovered rarely, and therapeutic impasses become real. Screening and identification of the resistance mechanisms (MRSA, ESBL, CRE,VRE) is essential to contain cross contamination and decrease antibiotic misuse.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have